| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/19/2008 | US20080145348 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/19/2008 | US20080145346 Using modulators of heterogeneous nuclear ribonucleoprotein (hnRNP) K binding as therapeutic in treatment of viral diseases |
| 06/19/2008 | US20080145340 Neuroactive agents and methods of their use |
| 06/19/2008 | US20080145339 Modified rolling circle initiator protein for use as therapeutic tool in suppression of viral replication and disorders |
| 06/19/2008 | US20080145315 Bioassay for monitoring protein-protein interactions associated with absorption, distribution, metabolism and excretion in animals and/or cells |
| 06/19/2008 | US20080145313 Treatment of cancer by means of RNA interference; compositions comprise small interfering nucleic acid molecule that suppresses expression of target gene involved in energy metabolism pathway within tumor cell, in biosynthesis of nucleotides, in glycogen metabolism, in transport of sugars, amino acids |
| 06/19/2008 | US20080141936 Electrospraying apparatus and method for coating particles |
| 06/19/2008 | CA2763879A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 06/19/2008 | CA2707542A1 Casein-derived peptides having anxiolytic activity |
| 06/19/2008 | CA2673085A1 Transferrin fusion protein libraries |
| 06/19/2008 | CA2672710A1 Selection method |
| 06/19/2008 | CA2672703A1 Antibodies against human cytomegalovirus (hcmv) |
| 06/19/2008 | CA2672581A1 Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same |
| 06/19/2008 | CA2672468A1 Human antibodies that bind cd70 and uses thereof |
| 06/19/2008 | CA2672393A1 Internalization |
| 06/19/2008 | CA2672229A1 Delivery of binding molecules to induce immunomodulation |
| 06/19/2008 | CA2672227A1 Herbicide-resistant sunflower plants and methods of use |
| 06/19/2008 | CA2672220A1 Impaired wound healing compositions and treatments |
| 06/19/2008 | CA2672163A1 Method of estimating secondary structure in rna and program and apparatus therefor |
| 06/19/2008 | CA2672083A1 Pathogen inducible plant trehalose-6-phophate phophatase gene promoters and regulatory elements |
| 06/19/2008 | CA2672055A1 Treatment of cachexia |
| 06/19/2008 | CA2672036A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 06/19/2008 | CA2671883A1 Synthetic agonists of tlr9 |
| 06/19/2008 | CA2671732A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/19/2008 | CA2671341A1 Plants having enhanced seed yield-related traits and a method for making the same |
| 06/19/2008 | CA2671302A1 Mirna regulated genes and pathways as targets for therapeutic intervention |
| 06/19/2008 | CA2671299A1 Functions and targets of let-7 micro rnas |
| 06/19/2008 | CA2671296A1 Mir-126 regulated genes and pathways as targets for therapeutic intervention |
| 06/19/2008 | CA2671294A1 Mir-21 regulated genes and pathways as targets for therapeutic intervention |
| 06/19/2008 | CA2671194A1 Mir-20 regulated genes and pathways as targets for therapeutic intervention |
| 06/19/2008 | CA2669137A1 Long term disease modification using immunostimulatory oligonucleotides |
| 06/19/2008 | CA2667502A1 Methods for improving antibody production |
| 06/19/2008 | CA2665678A1 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/19/2008 | CA2658836A1 Uses of disease gene promoters for providing therapeutic cell populations |
| 06/18/2008 | EP1933150A1 Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof |
| 06/18/2008 | EP1932926A2 Method of diagnosing ovarian endometriosis |
| 06/18/2008 | EP1932923A1 Method for determination of effective dose of methotrexate |
| 06/18/2008 | EP1932920A1 Method for screening of substance effective on disease using gpr120 and phospholipase |
| 06/18/2008 | EP1932917A2 Plant sterol acyltransferases |
| 06/18/2008 | EP1932916A1 Methods involving recombination of nucleic acid library members |
| 06/18/2008 | EP1932915A2 Materials and methods relating to improved vaccination strategies |
| 06/18/2008 | EP1932914A2 Caspase-9 deficient animals and the use thereof |
| 06/18/2008 | EP1932913A1 Nucleic acid isolation using polidocanol and derivatives |
| 06/18/2008 | EP1932912A1 Recombinant vector capable of increasing secretion of koji mold protease |
| 06/18/2008 | EP1932911A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/18/2008 | EP1932910A1 Process for production of lactic acid |
| 06/18/2008 | EP1932909A1 Plant producing hyaluronic acid |
| 06/18/2008 | EP1932908A1 Reporter vector for use in evaluation of cyp1a2 induction |
| 06/18/2008 | EP1932906A1 Method for producing nuclear-transplanted egg |
| 06/18/2008 | EP1932888A1 Labeling dye for biomolecule, labeling kit, and method for detecting biomolecule |
| 06/18/2008 | EP1932857A1 Preventive/remedy for cancer |
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932854A1 Lysosomal associated membrane protein (LAMP) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells |
| 06/18/2008 | EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host |
| 06/18/2008 | EP1932534A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 06/18/2008 | EP1932426A1 Gene delivery system and methods of use |
| 06/18/2008 | EP1931804A2 Combination therapy using budesonide and antisense oligonucleotide targeted to il4-receptor alpha |
| 06/18/2008 | EP1931792A2 Transgenic aloe plants for production of proteins and related methods |
| 06/18/2008 | EP1931791A2 Methods and compositions for the expression of a polynucleotide of interest |
| 06/18/2008 | EP1931790A1 Transgenic plant seed with increased lysine |
| 06/18/2008 | EP1931789A1 Methods for controlling gene expression using ta-siran |
| 06/18/2008 | EP1931788A2 Plants having increased yield and method for making the same |
| 06/18/2008 | EP1931785A2 Novel gene gms 01 |
| 06/18/2008 | EP1931784A2 Microorganisms with increased efficiency for methionine synthesis |
| 06/18/2008 | EP1931783A1 Chimeric hcn channels |
| 06/18/2008 | EP1931782A2 Methods for use in modulating mir-122a |
| 06/18/2008 | EP1931781A2 Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| 06/18/2008 | EP1931780A2 Antisense compounds having enhanced anti-microrna activity |
| 06/18/2008 | EP1931779A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 06/18/2008 | EP1931778A2 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-Bl00 EXPRESSION |
| 06/18/2008 | EP1931777A2 Products and methods relating to the use of the endoribonuclease kid/pemk |
| 06/18/2008 | EP1931775A2 Rubisco activase with increased thermostability and methods of use thereof |
| 06/18/2008 | EP1931772A2 Mutant reverse transcriptase and methods of use |
| 06/18/2008 | EP1931770A1 Nucleic acids encoding modified cytochrome p450 enzymes and methods of use thereof |
| 06/18/2008 | EP1931768A1 Use of a cellular extract for a mitotic remodeling of chromosomes |
| 06/18/2008 | EP1931710A2 Engineered anti-il-23 antibodies |
| 06/18/2008 | EP1931708A1 Il-17c antagonists and methods of using the same |
| 06/18/2008 | EP1931707A1 Rat trpm7 polynucleotide and encoded protein |
| 06/18/2008 | EP1931702A1 Silk proteins |
| 06/18/2008 | EP1931694A1 Aptamers comprising arabinose modified nucleotides |
| 06/18/2008 | EP1931377A1 Cd4+ t survivin epitopes and uses thereof |
| 06/18/2008 | EP1885850A4 D-psicose production method by d-psicose epimerase |
| 06/18/2008 | EP1807515A4 Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
| 06/18/2008 | EP1709164A4 Indole-diterpene biosynthesis |
| 06/18/2008 | EP1694825A4 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 06/18/2008 | EP1685243B1 Immortalized avian cell lines for virus production |
| 06/18/2008 | EP1622936B1 Method for the production of an n-terminally modified chemotactic factor |
| 06/18/2008 | EP1620569A4 A forward mutation assay based on 5-fluorouracil resistance |
| 06/18/2008 | EP1613769B1 Insulin-induced gene as therapeutic target in diabetes |
| 06/18/2008 | EP1527197B1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof |
| 06/18/2008 | EP1364003B1 G-protein fusion receptors |
| 06/18/2008 | EP1343895B1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/18/2008 | EP1322756B1 MANIPULATION OF PLANT SENESCENCE USING AN i MYB /i GENE PROMOTER AND CYTOKININ BIOSYNTHESIS GENES |
| 06/18/2008 | EP1319084B1 Nucleotide sequences which code for the mene gene |
| 06/18/2008 | EP1276850B1 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 06/18/2008 | EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/18/2008 | EP1242622B1 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |